![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Shaoxing Jingxin Pharmaceutical Co., Ltd. Shangyu Cn, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their significant offerings is Rosuvastatin calcium, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2019-309 - Rev 02
This Chemical Type CEP, issued on January 26, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2631 associated with this CEP further emphasizes